BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28320353)

  • 1. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
    Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
    BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
    Jögi A; Ehinger A; Hartman L; Alkner S
    PLoS One; 2019; 14(12):e0226150. PubMed ID: 31821370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
    Harrison H; Rogerson L; Gregson HJ; Brennan KR; Clarke RB; Landberg G
    Cancer Res; 2013 Feb; 73(4):1420-33. PubMed ID: 23248117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
    Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
    Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells.
    Wolff M; Kosyna FK; Dunst J; Jelkmann W; Depping R
    Arch Biochem Biophys; 2017 Jan; 613():23-30. PubMed ID: 27823907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study.
    Collin LJ; Maliniak ML; Cronin-Fenton DP; Ahern TP; Christensen KB; Ulrichsen SP; Damkier P; Hamilton-Dutoit S; Yacoub R; Christiansen PM; Sørensen HT; Lash TL
    Breast Cancer Res; 2021 Nov; 23(1):103. PubMed ID: 34736510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
    Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E
    Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
    Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
    J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
    Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
    Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eribulin Treatment Promotes Re-expression of Estrogen Receptor in Endocrine Therapy-resistant Hormone Receptor-positive Breast Cancer Cells.
    Goto W; Kashiwagi S; Iimori N; Kouhashi R; Yabumoto A; Takada K; Asano Y; Tauchi Y; Ogisawa K; Morisaki T; Shibutani M; Tanaka H; Maeda K
    Anticancer Res; 2023 Feb; 43(2):603-611. PubMed ID: 36697070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway.
    Liu C; Li S; Zhang X; Jin C; Zhao B; Li L; Miao QR; Jin Y; Fan Z
    Cancer Gene Ther; 2023 May; 30(5):647-658. PubMed ID: 36241702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.
    Yang J; AlTahan A; Jones DT; Buffa FM; Bridges E; Interiano RB; Qu C; Vogt N; Li JL; Baban D; Ragoussis J; Nicholson R; Davidoff AM; Harris AL
    Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15172-7. PubMed ID: 26598706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
    Ribas R; Pancholi S; Rani A; Schuster E; Guest SK; Nikitorowicz-Buniak J; Simigdala N; Thornhill A; Avogadri-Connors F; Cutler RE; Lalani AS; Dowsett M; Johnston SR; Martin LA
    Breast Cancer Res; 2018 Jun; 20(1):44. PubMed ID: 29880014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
    Fanale D; Bazan V; Corsini LR; Caruso S; Insalaco L; Castiglia M; Cicero G; Bronte G; Russo A
    Breast Cancer Res Treat; 2013 Aug; 140(3):505-17. PubMed ID: 23925655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 20. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells.
    Cho J; Kim D; Lee S; Lee Y
    Mol Endocrinol; 2005 May; 19(5):1191-9. PubMed ID: 15695373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.